Chemical Subtleties in Small-Molecule Modulation of Peptide Receptor Function: The Case of CXCR3 Biaryl-Type Ligands

被引:23
作者
Wijtmans, Maikel [1 ]
Scholten, Danny J. [1 ]
Roumen, Luc [1 ]
Canals, Meritxell [1 ]
Custers, Hans [1 ]
Glas, Marjolein [1 ]
Vreeker, Marlies C. A. [1 ]
de Kanter, Frans J. J. [2 ]
de Graaft, Chris [1 ]
Smit, Martine J. [1 ]
de Esch, Iwan J. P. [1 ]
Leurs, Rob [1 ]
机构
[1] Vrije Univ Amsterdam, Leiden Amsterdam Ctr Drug Res, Div Med Chem, Fac Sci, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Div Organ & Inorgan Chem, Fac Sci, Amsterdam, Netherlands
关键词
DRUG TARGETS; ANTAGONISTS; AGONISTS; INFLAMMATION; ACTIVATION; BIPHENYL; GPCR;
D O I
10.1021/jm301240t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The G protein-coupled chemokine receptor CXCR3 plays a role in numerous inflammatory events. The endogenous ligands for the chemokine receptors are peptides, but in this study we disclose small-molecule ligands that are able to activate CXCR3. A class of biaryl-type compounds that is assembled by convenient synthetic routes is described as a new class of CXCR3 agonists. Intriguingly, structure-activity relationship and structure-function relationship studies reveal that subtle chemical modifications on the outer aryl ring (e.g., either the size or position of a halogen atom) result in a full spectrum of agonist efficacies on CXCR3. Quantum mechanics calculations and nuclear Overhauser effect spectroscopy NMR studies suggest that the biaryl dihedral angle and the electronic nature of ortho-substituents play an important role in determining agonist efficacies. Compounds 38 (VUF11222) and 39 (VUF11418) are the first reported nonpeptidomimetic agonists on CXCR3, rendering them highly useful chemical tools for detailed assessment of CXCR3 activation as well as for studying downstream CXCR3 signaling.
引用
收藏
页码:10572 / 10583
页数:12
相关论文
共 36 条
  • [11] Single-bond torsional potentials in conjugated systems: A comparison of ab Initio and density functional results
    Karpfen, A
    Choi, CH
    Kertesz, M
    [J]. JOURNAL OF PHYSICAL CHEMISTRY A, 1997, 101 (40) : 7426 - 7433
  • [12] Status of GPCR Modeling and Docking as Reflected by Community-wide GPCR Dock 2010 Assessment
    Kufareva, Irina
    Rueda, Manuel
    Katritch, Vsevolod
    Stevens, Raymond C.
    Abagyan, Ruben
    Yoshikawa, Yasushi
    Furuya, Toshio
    Lee, Huisun
    Roy, Ambrish
    Grime, John
    Rebehmed, Joseph
    Zhang, Yang
    Roumen, Luc
    de Esch, Iwan J. P.
    Leurs, Rob
    de Graaf, Chris
    Li, Youyong
    Hou, Tingjun
    Mysinger, Michael M.
    Weiss, Dahlia R.
    Irwin, John J.
    Shoichet, Brian K.
    McRobb, Fiona M.
    Capuano, Ben
    Crosby, Ian T.
    Chalmers, David K.
    Yuriev, Elizabeth
    Wang, Qi
    Mach, Robert H.
    Reichert, David E.
    Chuang, Gwo-Yu
    Rognan, Didier
    Simms, John
    Sexton, Patrick
    Wootten, Denise
    Latek, Dorota
    Ghoshdastider, Umesh
    Filipek, Slawomir
    Kirkpatrick, Andrea
    Trzaskowski, Bartosz
    Griffith, Adam
    Kim, Soo-Kyung
    Abrol, Ravinder
    Goddard, William A., III
    Vaidehi, Nagarajan
    Lam, Alfonso
    Bhattacharya, Supriyo
    Li, Hubert
    Balaraman, Gouthaman
    Niesen, Michiel
    [J]. STRUCTURE, 2011, 19 (08) : 1108 - 1126
  • [13] Residual dipolar couplings in NMR structure analysis
    Lipsitz, RS
    Tjandra, N
    [J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2004, 33 : 387 - 413
  • [14] CXCR3 antagonists
    Medina, JC
    Johnson, MG
    Collins, TL
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 215 - 225
  • [15] Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3
    Nedjai, Belinda
    Li, Hubert
    Stroke, Ilana L.
    Wise, Emma L.
    Webb, Maria L.
    Merritt, J. Robert
    Henderson, Ian
    Klon, Anthony E.
    Cole, Andrew G.
    Horuk, Richard
    Vaidehi, Nagarajan
    Pease, James E.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (03) : 912 - 923
  • [16] Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation
    O'Boyle, Graeme
    Fox, Christopher R. J.
    Walden, Hannah R.
    Willet, Joseph D. P.
    Mavin, Emily R.
    Hine, Dominic W.
    Palmer, Jeremy M.
    Barker, Catriona E.
    Lamb, Christopher A.
    Ali, Simi
    Kirby, John A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (12) : 4598 - 4603
  • [17] Opinion - How many drug targets are there?
    Overington, John P.
    Al-Lazikani, Bissan
    Hopkins, Andrew L.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) : 993 - 996
  • [18] Controlling the helicity of 2,2′-bipyridyl ruthenium(II) and zinc(II) hemicage complexes
    Oyler, Karl D.
    Coughlin, Frederick J.
    Bernhard, Stefan
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (01) : 210 - 217
  • [19] Halogen bonding in halocarbon-protein complexes: a structural survey
    Parisini, Emilio
    Metrangolo, Pierangelo
    Pilati, Tullio
    Resnati, Giuseppe
    Terraneo, Giancarlo
    [J]. CHEMICAL SOCIETY REVIEWS, 2011, 40 (05) : 2267 - 2278
  • [20] In Silico Veritas: The Pitfalls and Challenges of Predicting GPCR-Ligand Interactions
    Roumen, Luc
    Sanders, Marijn P. A.
    Vroling, Bas
    de Esch, Iwan J. P.
    de Vlieg, Jacob
    Leurs, Rob
    Klomp, Jan P. G.
    Nabuurs, Sander B.
    de Graaf, Chris
    [J]. PHARMACEUTICALS, 2011, 4 (09): : 1196 - 1215